Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD
Clinical trial NCT02343458 · COMPLETED
Trial details
- NCT number
- NCT02343458
- Sponsor
- Pearl Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-30
- Primary completion
- 2017-08-31
- Enrollment
- 1756
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.